Patric Nelson
Corporate Officer/Principal bij VIRACTA THERAPEUTICS, INC.
Oorsprong van het eerstegraads netwerk van Patric Nelson
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 25 | |
| Public Company | Pharmaceuticals: Major | 17 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Patric Nelson via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Compliance Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MARINUS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Aisling Capital LLC
 Aisling Capital LLC Investment ManagersFinance Aisling Capital LLC (Aisling Capital) is an venture capital firm founded in 1999 by Dennis Joseph Purcell. The firm is headquartered in New York, New York. | Investment Managers | Private Equity Investor Private Equity Investor | |
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Executive Officer Sales & Marketing | |
| The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Undergraduate Degree | |
| SILENCE THERAPEUTICS PLC | Miscellaneous Commercial Services | Chief Executive Officer | |
Permira Advisers LLP
 Permira Advisers LLP Investment ManagersFinance Permira Advisers LLP (Permira Advisers) is a private equity subsidiary of Permira Holdings Ltd founded in 1985 by Peter M. Smitham. The firm is headquartered in London, United Kingdom with additional offices in the United States and Asia. | Investment Managers | Consultant / Advisor | |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
| University of Cambridge | College/University | Graduate Degree | |
| San Diego State University | College/University | Undergraduate Degree Masters Business Admin | |
| The Johns Hopkins University | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| INSEAD | College/University | Masters Business Admin | |
| University of California San Diego | College/University | Corporate Officer/Principal Masters Business Admin | |
| University of San Diego | College/University | Undergraduate Degree Undergraduate Degree | |
Otsuka America Pharmaceutical, Inc.
 Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Otsuka America Pharmaceutical, Inc. manufactures and supplies pharmaceutical products. It develops drugs for neuroscience, cardiovascular, and gastrointestinal treatments. The company was founded in 1989 and is headquartered in Rockville, MD. | Pharmaceuticals: Major | Corporate Officer/Principal Compliance Officer Chief Tech/Sci/R&D Officer | |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Medical Specialties | President | |
| Sidney Kimmel Medical College | College/University | Corporate Officer/Principal | |
| CONTRAFECT CORPORATION | Biotechnology | Chief Executive Officer Director/Board Member | |
| Albert Einstein College of Medicine, Inc. | College/University | Corporate Officer/Principal Doctorate Degree | |
| Tibotec Pharmaceuticals | Chief Executive Officer | ||
| COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Chairman | |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Medical/Nursing Services | Director/Board Member | |
| THERAPEUTICSMD, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Real Endpoints LLC
 Real Endpoints LLC Data Processing ServicesTechnology Services Real Endpoints LLC provides information and analytics services. It offers information platform to reveal insights about the changing world of product reimbursement. The firm operates its business through Reimbursement Intelligence and RxScorecard. The company was founded by Roger Longman in 2010 and is headquartered in Westport, CT. | Data Processing Services | Chief Executive Officer Corporate Officer/Principal | |
| SERES THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer | |
| LOXO ONCOLOGY INC | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin Masters Business Admin | |
| Yale School of Medicine | College/University | Doctorate Degree Corporate Officer/Principal | |
Genpharm Services
 Genpharm Services Advertising/Marketing ServicesCommercial Services Genpharm Services operates as a pharmaceutical company providing partners with market access and commercial solutions into the Middle East and North Africa region. It also acts as a commercial partner for rare genetic diseases, orphan drugs, and specialty therapeutics and offers strategic advice on disease areas, product launches and go-to markets strategies. The company was founded by Karim Smaira and Kamel Ghammachi in 2012 and is headquartered in Dubai, United Arab Emirates. | Advertising/Marketing Services | Director/Board Member | |
Orchard Therapeutics (Europe) Ltd.
 Orchard Therapeutics (Europe) Ltd. BiotechnologyHealth Technology Orchard Therapeutics (Europe) Ltd. researches on transformative gene therapies. Its services include stem cell technology, gene therapy, eradicating orphan diseases, and paediatric diseases. The company was founded by Andrea Spezzi and Nicolas Koebel on September 1, 2015 and is headquartered in London, the United Kingdom. | Biotechnology | Chief Executive Officer | |
Silicon INSITE, Inc.
 Silicon INSITE, Inc. BiotechnologyHealth Technology Silicon Therapeutics LLC operates as an integrated computational drug discovery company that focuses on developing novel medicines for diseases. Its INSITE platform closely represents the dynamical nature of targets using all-atom simulations. The firm has offices in Boston and Shanghai. The company was founded by Lijun Sun, Peiqi Sun, Elliot L. Chaikof, and Finith Jernigan, III in 2016 and is headquartered in Boston, MA. | Biotechnology | Chairman | |
Viracta Subsidiary, Inc.
 Viracta Subsidiary, Inc. BiotechnologyHealth Technology Viracta Subsidiary, Inc. engages in the development of proprietary viral gene activation therapy to address cancers associated with the Epstein-Barr virus. Its platform is designed as a targeted approach to treat a range of viral-associated cancers and other serious diseases. The company was founded by Ronald J. Berenson, Douglas V. Faller, George C. Hillman, Thalia Papayannopoulou, Susan P. Perrine, George Stamatoyannopoulos, and Robert Williams and is headquartered in Cardiff, CA. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member Chairman Chief Tech/Sci/R&D Officer Director of Finance/CFO Director/Board Member Director/Board Member | |
| ORCHARD THERAPEUTICS PLC | Pharmaceuticals: Major | Chief Executive Officer | |
| ARAVIVE, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
Orchard Therapeutics North America
 Orchard Therapeutics North America BiotechnologyHealth Technology Part of Orchard Therapeutics Plc, Orchard Therapeutics North America provides biotechnology research services. The company is based in Boston, MA. The CEO of the company is Bobby Gaspar. | Biotechnology | President | |
| ENLIVEX THERAPEUTICS LTD. | Biotechnology | Director/Board Member | |
| INDAPTUS THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
Verimmune, Inc.
 Verimmune, Inc. BiotechnologyHealth Technology Verimmune, Inc. is a company based in Washington that is dedicated to developing a first-in-class cancer immunotherapy called anti-tumor immune redirection (AIR). Verimmune's proprietary virus-inspired particle (VIP) technology platform redirects pre-existing pathogenic or childhood vaccine immune memory toward tumors. The American company's lead immuno-oncology product candidate, Veri-101, harnesses the cellular immune memory responses from prior cytomegalovirus (CMV) infection to fight cancer. This mechanism of action has the potential to redefine the treatment paradigm for patients with untreatable cancers or resistance to existing therapies. The company was founded in 1995 by John Troyer and Joshua Weiyuan Wang, with Joshua Weiyuan Wang serving as the CEO since then. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 39 |
| Verenigd Koninkrijk | 5 |
| Israël | 3 |
| Singapore | 2 |
| Frankrijk | 2 |
Sectoraal
| Health Technology | 29 |
| Consumer Services | 12 |
| Finance | 3 |
| Commercial Services | 3 |
| Health Services | 3 |
Operationeel
| Director/Board Member | 210 |
| Corporate Officer/Principal | 126 |
| Independent Dir/Board Member | 72 |
| Chief Executive Officer | 41 |
| President | 39 |
Sterkste connecties
| Insiders | |
|---|---|
| Gil Omenn | 42 |
| Ivor Royston | 30 |
| Jay Shepard | 30 |
| Roger Pomerantz | 30 |
| Dov Goldstein | 28 |
| Jeffrey Berkowitz | 26 |
| Scott Braunstein | 26 |
| Alan Fuhrman | 17 |
| Nicole Onetto | 17 |
| Gur Roshwalb | 17 |
| Michael Huang | 15 |
| Eric Warren | 15 |
| Jane Barlow | 15 |
| Barry Simon | 15 |
| Mark Rothera | 14 |
- Beurs
- Insiders
- Patric Nelson
- Bedrijfsconnecties
